Latest Breaking News On - Immutep limited - Page 5 : comparemela.com

Immutep Announces Site Expansion for INSIGHT-003 Phase I Trial

Immutep Announces Site Expansion for INSIGHT-003 Phase I Trial
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Nordrhein westfalenNew south walesUnited statesSalah eddin al batranChris bastaMerck co incMerck sharp dohmeUniversity clinic of ruhr universitCorporate communicationsFrankfurt institute of clinical cancer researchImmutep limitedAnnounces site expansionUniversity clinicRuhr universitLung clinicProportion score

Immutep Announces Site Expansion for INSIGHT-003 Phase I Trial

Immutep Announces Site Expansion for INSIGHT-003 Phase I Trial
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

New south walesNordrhein westfalenUnited statesSalah eddin al batranChris bastaMerck sharp dohmeMerck co incImmutep limitedUniversity clinic of ruhr universitCorporate communicationsFrankfurt institute of clinical cancer researchUniversity clinicRuhr universitLung clinicProportion scoreFrankfurt institute

Immutep Announces Completion of the Safety Lead-In and Opening of the Randomized Phase II of the AIPAC-003 Phase II/III Trial in Metastatic Breast Cancer

Immutep Announces Completion of the Safety Lead-In and Opening of the Randomized Phase II of the AIPAC-003 Phase II/III Trial in Metastatic Breast Cancer
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

New south walesUnited statesChris bastaCorporate communicationsDrug administrationImmutep limitedData monitoring committeeAnnounces completionSafety lead inRandomized phaseMetastatic breastEftilagimod alphaFast track designationUnited states foodLymphocyte activationInvestor relations

Triple-Negative Breast Cancer Clinical Trial Pipeline Insights | 75+ Key Companies Investigating Their Lead Candidates to Improve the Treatment Space |

Triple-Negative Breast Cancer Clinical Trial Pipeline Insights | 75+ Key Companies Investigating Their Lead Candidates to Improve the Treatment Space |
medgadget.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medgadget.com Daily Mail and Mail on Sunday newspapers.

United statesKlus pharmaCamrelizumab airuikaAkeso biopharmaChipscreen biosciencesNueva vidaNugenerex immunoBiolite incBreast cancer companiesModernatx incSeagen incNovartis pharmaceuticalsShanghai junshi biosciences co ltdImmunitybio incAmerican association for cancer researchJiangsu alphamab biopharmaceuticals co ltd

Immutep to Participate in November Investor Events

Immutep to Participate in November Investor Events
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

New south walesChris bastaWade iamsMarc voigtChristian muellerFrederic triebelImmutep limitedCorporate communicationsNovember investorAssistant professorDirector thoracic clinical trialsVanderbilt university medical centerLymphocyte activationInvestor relations